Shirley Glasgow

Statistics

Publications

Citations

H-Index

Active since

2014

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Shirley Glasgow is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacokinetics of monoclonal antibodies, psoriasis therapy, and subjects.

Publications per year

2014–2018

Publications

Pharmacokinetics of Tildrakizumab (MK‐3222), an Anti‐IL‐23 Monoclonal Antibody, After Intravenous or Subcutaneous Administration in Healthy Subjects

Sauzanne Khalilieh, Peter Hodsman, Christine Xu et al. · Basic & Clinical Pharmacology & Toxicology · 2018 · 36 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Tildrakizumab, a novel anti-IL-23 monoclonal antibody, is unaffected by ethnic variability in Caucasian, Chinese, and Japanese subjects

Anthe S. Zandvliet, Shirley Glasgow, Ann D. Horowitz et al. · International Journal of Clinical Pharmacology and Therapeutics · 2014 · 22 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

1–2 of 2